FDA inspection
AcelRx Pharmaceuticals, Inc.: FDA inspection ending Feb 13, 2020
FDA inspection 1117803 · Voluntary Action Indicated (VAI) · Hayward, CA
Key facts
| Inspection ID | 1117803 |
|---|---|
| Firm | AcelRx Pharmaceuticals, Inc. |
| FEI number | 3006386491 |
| Address | 351 Galveston Dr |
| City | Hayward |
| State | CA |
| ZIP | 94545 |
| Country | United States |
| Fiscal year | 2020 |
| Inspection end date | Feb 13, 2020 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data